Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Michelle Fullard

Concepts (101)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Parkinson Disease
18
2024
463
4.450
Why?
Olfaction Disorders
4
2021
60
1.320
Why?
Cognitive Dysfunction
5
2021
346
1.070
Why?
Deep Brain Stimulation
2
2024
125
0.950
Why?
Arthroplasty, Replacement, Hip
1
2020
137
0.570
Why?
Decision Making
1
2024
851
0.570
Why?
Patient Readmission
2
2020
667
0.560
Why?
Disabled Persons
1
2017
140
0.500
Why?
Vitamin D Deficiency
1
2017
176
0.490
Why?
Arthroplasty, Replacement, Knee
1
2020
305
0.480
Why?
Length of Stay
1
2020
1127
0.450
Why?
Physical Therapy Modalities
1
2017
292
0.450
Why?
Vitamin D
1
2017
384
0.440
Why?
Patient Discharge
1
2020
857
0.420
Why?
Sex Characteristics
1
2017
737
0.400
Why?
Medicare
4
2019
720
0.400
Why?
Healthcare Disparities
2
2019
578
0.400
Why?
Patient Acceptance of Health Care
1
2017
759
0.370
Why?
Aged
15
2024
22103
0.350
Why?
Dementia
2
2023
227
0.280
Why?
Alzheimer Disease
2
2023
519
0.250
Why?
Aged, 80 and over
6
2020
7086
0.250
Why?
Middle Aged
11
2024
31154
0.220
Why?
Male
15
2024
63681
0.210
Why?
Lewy Body Disease
1
2023
29
0.200
Why?
Cannabidiol
1
2024
108
0.190
Why?
Female
14
2024
68776
0.190
Why?
Dronabinol
1
2024
203
0.190
Why?
Humans
19
2024
129650
0.180
Why?
Patient Selection
1
2024
663
0.170
Why?
United States
6
2024
13903
0.170
Why?
Cholinesterase Inhibitors
1
2019
29
0.150
Why?
Cholinergic Antagonists
1
2019
29
0.150
Why?
Leukoencephalopathies
1
2018
21
0.150
Why?
Elective Surgical Procedures
1
2020
165
0.150
Why?
Cohort Studies
3
2017
5420
0.150
Why?
Medication Errors
1
2019
95
0.150
Why?
Geography, Medical
1
2017
11
0.140
Why?
Databases, Factual
2
2020
1269
0.140
Why?
Dopamine Plasma Membrane Transport Proteins
1
2017
47
0.140
Why?
Disease Progression
4
2019
2635
0.140
Why?
Proportional Hazards Models
2
2019
1201
0.130
Why?
White Matter
1
2018
136
0.130
Why?
Drug Prescriptions
1
2019
248
0.130
Why?
Biomarkers
2
2019
3973
0.130
Why?
REM Sleep Behavior Disorder
1
2016
14
0.130
Why?
Diagnosis, Differential
2
2017
1434
0.120
Why?
tau Proteins
1
2016
78
0.120
Why?
Longitudinal Studies
3
2019
2717
0.120
Why?
Neuropsychological Tests
2
2018
1015
0.120
Why?
Risk
1
2017
854
0.120
Why?
Cognition Disorders
1
2018
505
0.110
Why?
Salivary Ducts
1
2013
2
0.110
Why?
Myelitis, Transverse
1
2013
3
0.110
Why?
Carcinoma, Ductal
1
2013
11
0.110
Why?
Parotid Neoplasms
1
2013
16
0.110
Why?
Spinal Cord Neoplasms
1
2013
40
0.110
Why?
Amyloid beta-Peptides
1
2016
213
0.110
Why?
Proteomics
1
2019
1062
0.100
Why?
Logistic Models
1
2017
1988
0.100
Why?
Incidence
1
2017
2644
0.090
Why?
Prevalence
1
2017
2564
0.090
Why?
Cognition
1
2018
1123
0.090
Why?
Prognosis
1
2017
3794
0.080
Why?
Exercise
1
2018
1925
0.060
Why?
Brain
1
2018
2679
0.060
Why?
Vulnerable Populations
1
2024
158
0.050
Why?
Community-Based Participatory Research
1
2024
148
0.050
Why?
Retrospective Studies
1
2020
14518
0.050
Why?
Minority Groups
1
2024
249
0.050
Why?
Adult
3
2020
35576
0.050
Why?
Educational Status
1
2024
470
0.050
Why?
Osteopontin
1
2019
31
0.040
Why?
Amidohydrolases
1
2019
30
0.040
Why?
Smell
1
2021
137
0.040
Why?
Double-Blind Method
1
2024
1876
0.040
Why?
Drug Incompatibility
1
2019
1
0.040
Why?
Proteoglycans
1
2019
110
0.040
Why?
Extracellular Matrix Proteins
1
2019
144
0.040
Why?
Neurodegenerative Diseases
1
2019
113
0.040
Why?
Social Class
1
2019
257
0.040
Why?
Acute Disease
1
2019
980
0.030
Why?
Health Knowledge, Attitudes, Practice
1
2024
1279
0.030
Why?
Carrier Proteins
1
2019
743
0.030
Why?
Life Style
1
2018
460
0.030
Why?
Internationality
1
2016
149
0.030
Why?
Risk Factors
2
2019
9765
0.030
Why?
Resistance Training
1
2018
151
0.030
Why?
Comorbidity
1
2019
1547
0.030
Why?
Self Report
1
2018
799
0.030
Why?
Thoracic Vertebrae
1
2013
74
0.030
Why?
Fatal Outcome
1
2013
300
0.030
Why?
Syndrome
1
2013
341
0.030
Why?
Algorithms
1
2019
1622
0.020
Why?
Reproducibility of Results
1
2019
3083
0.020
Why?
Radiography
1
2013
798
0.020
Why?
Treatment Outcome
1
2024
10230
0.020
Why?
Cross-Sectional Studies
1
2019
5066
0.020
Why?
Follow-Up Studies
1
2016
4897
0.020
Why?
Magnetic Resonance Imaging
1
2018
3408
0.020
Why?
Prospective Studies
1
2016
7133
0.010
Why?
Fullard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)